ESSA Pharma Inc.
EPIX
$1.72
$0.010.59%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 4.21M | 3.51M | 3.17M | 4.32M | 2.22M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.68M | 7.69M | 8.64M | 10.49M | 7.59M |
| Operating Income | -9.68M | -7.69M | -8.64M | -10.49M | -7.59M |
| Income Before Tax | -8.53M | -6.36M | -7.23M | -8.99M | -5.96M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -8.53M | -6.36M | -7.23M | -8.99M | -5.96M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.53M | -6.36M | -7.23M | -8.99M | -5.96M |
| EBIT | -9.68M | -7.69M | -8.64M | -10.49M | -7.59M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.19 | -0.14 | -0.16 | -0.20 | -0.14 |
| Normalized Basic EPS | -0.12 | -0.09 | -0.10 | -0.13 | -0.08 |
| EPS Diluted | -0.19 | -0.14 | -0.16 | -0.20 | -0.14 |
| Normalized Diluted EPS | -0.12 | -0.09 | -0.10 | -0.13 | -0.08 |
| Average Basic Shares Outstanding | 44.39M | 44.37M | 44.37M | 44.24M | 44.13M |
| Average Diluted Shares Outstanding | 44.39M | 44.37M | 44.37M | 44.24M | 44.13M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |